Search results
Results From The WOW.Com Content Network
Vaccine Choice issued "Adding Insult To Injury Awards" in 2016 and 2017 to media outlets that produced news reports it disliked. The host of one program was thus targeted, The Sunday Edition's Michael Enright, sarcastically accepted the award with pride, on behalf of the Canadian Broadcasting Corporation.
December 23, 2010 Nu-Pharm Inc v Canada (AG), 2010 SCC 65 : January 20/21, 2010 December 23, 2010 Canadian Food Inspection Agency v Professional Institute of the Public Service of Canada, 2010 SCC 66 : January 20, 2010 December 23, 2010 Manuge v Canada, 2010 SCC 67 : January 20, 2010 December 23, 2010
The Supreme Court of Canada is the court of last resort and final appeal in Canada. Cases successfully appealed to the Court are generally of national importance. Once a case is decided, the Court publishes written reasons for the decision, that consist of one or more opinions from any number of the nine justices.
Vaccine makers such as Pfizer (PFE) are breathing much easier today: The Supreme Court ruled they can't be sued for defective vaccine designs. That puts the kibosh on some 5,000 cases in which ...
The lawsuit filed by React19 and other patients argues the CICP's high rejection rate is a product of a flawed design that includes an exceedingly short deadline for filing for compensation and an ...
In March 2021, amid supply shortages, NACI issued a strong recommendation that second doses of two-dose COVID-19 vaccines (such as the AstraZeneca, Moderna, and Pfizer vaccines) be given up to four months after the first, as opposed to the three-to-four week intervals used in the clinical trials and recommended by Health Canada. NACI stated ...
Biotech firm Promosome LLC sued Moderna, Pfizer and BioNTech in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a patent related to messenger RNA ...
2010 Allergan [16] $600 million Off-label promotion Botox: False Claims Act, FDCA 2010 AstraZeneca [17] $520 million Off-label promotion, kickbacks Seroquel: False Claims Act 2007 Bristol-Myers Squibb [18] $515 million Off-label promotion, kickbacks, Medicare fraud Abilify, Serzone: False Claims Act, FDCA 2002 Schering-Plough [19] $500 million